Substantial evidence indicates that serum FABP4 levels are significantly elevated in patients with metabolic disorders such as diabetes, insulin resistance, obesity, and atherosclerosis [32]. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.